Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?

Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?

Source: 
Motley Fool
snippet: 
  • Last December, Pfizer formed a new company with Roivant Sciences to trial an experimental IBD medication.
  • The therapy sports a novel mechanism of action and it could be used to treat dozens of high-value indications.
  • While this decision may not make sense at first, Pfizer probably made the right move in this situation.